Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Tuesday's Intraday Session

Author: Benzinga Insights | January 03, 2023 01:30pm

Gainers

  • Jasper Therapeutics (NASDAQ:JSPR) shares moved upwards by 576.1% to $3.27 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 39.7 million shares, making up 55465.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $121.0 million.
  • Lucira Health (NASDAQ:LHDX) stock increased by 512.33% to $0.68. Trading volume for Lucira Health's stock is 119.7 million as of 12:30 EST. This is 35583.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $27.6 million.
  • Reshape Lifesciences (NASDAQ:RSLS) shares moved upwards by 96.73% to $13.26. The current volume of 8.8 million shares is 28689.1% of Reshape Lifesciences's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $6.4 million.
  • Scilex Holding (NASDAQ:SCLX) shares rose 41.6% to $5.65. Scilex Holding's stock is trading at a volume of 291.0K shares as of 12:30 EST. This is 459.4% of its average full-day volume over the last 100 days. The company's market cap stands at $798.6 million.
  • 180 Life Sciences (NASDAQ:ATNF) stock rose 37.75% to $4.67. 180 Life Sciences's stock is trading at a volume of 23.6 million shares as of 12:30 EST. This is 1125.5% of its average full-day volume over the last 100 days. The company's market cap stands at $17.4 million.
  • Idera Pharmaceuticals (NASDAQ:IDRA) stock moved upwards by 34.28% to $0.47. As of 12:30 EST, Idera Pharmaceuticals's stock is trading at a volume of 653.2K, which is 584.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $29.3 million.

Losers

  • Palisade Bio (NASDAQ:PALI) shares declined by 25.4% to $3.88 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 4.1 million shares, making up 139.7% of its average full-day volume over the last 100 days. The company's market cap stands at $5.5 million.
  • Dermata Therapeutics (NASDAQ:DRMA) stock decreased by 24.72% to $0.31. As of 12:30 EST, Dermata Therapeutics's stock is trading at a volume of 2.9 million, which is 189.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.7 million.
  • Scopus BioPharma (NASDAQ:SCPS) stock decreased by 20.76% to $0.1. The market value of their outstanding shares is at $2.2 million.
  • Cano Health (NYSE:CANO) stock declined by 16.43% to $1.15. Cano Health's stock is trading at a volume of 6.1 million shares as of 12:30 EST. This is 49.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $280.0 million.
  • Kala Pharmaceuticals (NASDAQ:KALA) shares declined by 16.13% to $32.0. The current volume of 4.4 million shares is 249.6% of Kala Pharmaceuticals's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $51.0 million.
  • Ambrx Biopharma (NYSE:AMAM) shares decreased by 16.08% to $1.91. The current volume of 477.5K shares is 14.1% of Ambrx Biopharma's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $73.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: AMAM ATNF CANO DRMA IDRA JSPR KALA LHDX PALI RSLS SCLX SCPS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist